Idorsia Ltd. (IDRSF)

5.30 -0.30 (-5.36%) USD  |  OTCM  |  Sep 24, 16:00
More

Idorsia Research and Development Expense (Annual) : 121.54M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for IDRSF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Research and Development Expense (Annual) Data

View and export this data back to 2016. Start Trial.
Date Value
December 31, 2025 121.54M
December 31, 2024 153.50M
December 31, 2023 316.58M
December 31, 2022 387.34M
December 31, 2021 437.13M
Date Value
December 31, 2020 391.38M
December 31, 2019 424.75M
December 31, 2018 361.20M
December 31, 2017 137.07M
December 31, 2016 286.87M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Basilea Pharmaceutica AG 127.51M
Santhera Pharmaceuticals Holding AG 26.75M
BeOne Medicines Ltd. 2.079B
AC Immune SA 67.96M
CRISPR Therapeutics AG 265.33M